X-group (possible homology)

586 Stathmin

Ligands and drugs

379
Member domains
150
with ligand contacts (≤ 4 Å)
39.6% of members
160
with DrugDomain annotations
42.2% of members
51
with a DrugBank compound
13.5% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

2
Proteins with classified ligands
4
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Benzenoids10.16.94×not tested
Organoheterocyclic compounds10.33.29×not tested
Organic acids and derivatives10.33.28×not tested
Homogeneous metal compounds21.02.07×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB01206——1
DB07574—2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE1

Most frequently bound compounds

PDB ligandNameDomains in contact
CAmetalCALCIUM ION110
A1L2T~{N}4-(1,3-benzodioxol-5-ylmethyl)-6-(1~{H}-indol-4-yl)pyrimidine-2,4-diamine1
LVV4-[(4-methylphenyl)methyl]-1,4-thiazinane 1,1-dioxide1
NUY[4-(propan-2-yl)piperazin-1-yl](thiophen-2-yl)methanone1
UR13-fluoro-5-methylbenzene-1-sulfonamide1
WZP2-methyl-1-[4-(propan-2-yl)piperazin-1-yl]propan-1-one1
WZYN-(4-methoxyphenyl)glycinamide1
X1M1-(6-methoxypyridin-2-yl)-N-methylmethanamine1